Impact on Obesity-Related Illnesses and Quality of Life Following Intragastric Balloon

Background The impact of intragastric balloon (IGB) on obesity-related illnesses and quality of life (QOL) has not been previously investigated. Method One hundred and nineteen consecutive obese patients (86 females; mean age 37.8; mean body weight (BW) 103.7 ± 24.1 kg; mean BMI 38.4 ± 8.0 kg/m 2 )...

Full description

Saved in:
Bibliographic Details
Published in:Obesity surgery 2010-08, Vol.20 (8), p.1128-1132
Main Authors: Mui, Wilfred Lik-Man, Ng, Enders Kwok-Wai, Tsung, Bonnie Yuk-San, Lam, Chuen Hing, Yung, Man Yee
Format: Article
Language:English
Subjects:
Adult
Anthropometry
Body Mass Index
Comorbidity
Female
Gastric Balloon
Humans
Male
Medical treatment
Medicine
Medicine & Public Health
Obesity
Obesity, Morbid - psychology
Obesity, Morbid - therapy
Quality of Life
Research Article
Surgery
Treatment Outcome
Weight Loss
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The impact of intragastric balloon (IGB) on obesity-related illnesses and quality of life (QOL) has not been previously investigated. Method One hundred and nineteen consecutive obese patients (86 females; mean age 37.8; mean body weight (BW) 103.7 ± 24.1 kg; mean BMI 38.4 ± 8.0 kg/m 2 ) who underwent IGB were evaluated for improvement on obesity-related illnesses and QOL after weight reduction in a multidisciplinary university referral center. Bioenterics Intragastric balloon (BIB®) system was employed in the study. Results Mean treatment period was 169.9 ± 34.8 days. Mean BW, BMI, and excess body weight loss were 12.4 ± 6.9 kg, 4.6 ± 2.7 kg/m 2 , and 45.1 ± 35.3%. Mean waist circumference and biceps fold and triceps fold loss were 10.5 ± 8.3, 9.8 ± 8.5, and 8.7 ± 7.4 cm respectively. Metabolic syndrome was decreased from 42.9% to 15.1% after IGB ( p  
ISSN:0960-8923
1708-0428
DOI:10.1007/s11695-008-9766-6